The duration of oral anticoagulant therapy after a second episode of venous thromboembolism

New England Journal of Medicine

Volumn 336, Issue 6, 1997, Pages 393-398

  Schulman, Sam ^a   Granqvist, Staffan ^j   Holmström, Margareta ^a   Carlsson, Anders ^b   Lindmarker, Per ^a   Nicol, Peter ^c   Eklund, Sven Gunnar ^d   Nordlander, Sune ^e   Lärfars, Gerd ^f   Leijd, Barbro ^g   Linder, Olle ^h   Loogna, Enno ⁱ   Walter, Hans ^k   Viering, Stanka ^l   Hjorth, Martin ^m   Boberg, Jonas ⁿ  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c Köping Hospital   (Sweden)

^d Division of Obstetrics and Gynecology Södertälje Hospital   (Sweden)

^e CENTRAL HOSPITAL   (Sweden)

^f STOCKHOLM SÖDER HOSPITAL   (Sweden)

^g ST GÖRAN S HOSPITAL   (Sweden)

^h ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

ⁱ Nacka Hospital   (Sweden)

^j ERSTA HOSPITAL   (Sweden)

^k Sabbatsberg Hospital   (Sweden)

^l NORRTÄLJE HOSPITAL   (Sweden)

^m Lidkoping Hospital   (Sweden)

ⁿ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DICOUMAROL; HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT PLANNING; VEIN THROMBOSIS;

EID: 8044235654     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199702063360601     Document Type: Article

References (7)

1. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992;340:873-6.
2. Schulman S, Rhedin A-S, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661-5.
3. Schulman S, Lockner D, Juhlin-Dannfelt A. The duration of oral anticoagulation after deep vein thrombosis: a randomized study. Acta Med Scand 1985;217:547-52.
4. Johansson J, Johnsson H, Wilhelmsson S. Diagnos och behandling av venös tromboembolism vid svenska internmedicinska kliniker - en översikt. Lakartidningen 1987;84:22-5.
5. Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1993;102:Suppl:408S-425S. [Erratum, Chest 1993;103:1636.]
6. Schulman S, Stigendal L, Jansson J-H, Brohult J. Haemorrhagic and thromboembolic complications versus intensity of treatment of venous thromboembolism with oral anticoagulants. Acta Med Scand 1988;224:425-30.
7. Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260-4.